Crescita Therapeutics (CTX) Competitors

Crescita Therapeutics (TSE:CTX) and HEXO (TSE:HEXO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Is CTX or HEXO more profitable?

Crescita Therapeutics has a net margin of -17.72% compared to HEXO's net margin of -220.13%. Crescita Therapeutics' return on equity of -15.79% beat HEXO's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescita Therapeutics	-17.72%	-15.79%	-8.26%
HEXO	-220.13%	-106.39%	-14.96%

Does the MarketBeat Community favor CTX or HEXO?

Crescita Therapeutics received 3 more outperform votes than HEXO when rated by MarketBeat users. Likewise, 67.42% of users gave Crescita Therapeutics an outperform vote while only 47.90% of users gave HEXO an outperform vote.

Company	Underperform	Outperform
Crescita Therapeutics	Outperform Votes 60 67.42%	Underperform Votes 29 32.58%
HEXO	Outperform Votes 57 47.90%	Underperform Votes 62 52.10%

Which has stronger earnings & valuation, CTX or HEXO?

Crescita Therapeutics has higher earnings, but lower revenue than HEXO. Crescita Therapeutics is trading at a lower price-to-earnings ratio than HEXO, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescita Therapeutics	C$16.84M	0.69	-C$2.98M	-C$0.15	-4.00
HEXO	C$124.10M	0.00	-C$273.18M	-C$3.41	N/A

Does the media prefer CTX or HEXO?

In the previous week, Crescita Therapeutics' average media sentiment score of 0.00 equaled HEXO'saverage media sentiment score.

Company	Overall Sentiment
Crescita Therapeutics	Neutral
HEXO	Neutral

Which has more volatility and risk, CTX or HEXO?

Crescita Therapeutics has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Comparatively, HEXO has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of CTX or HEXO?

7.6% of HEXO shares are held by institutional investors. 10.9% of Crescita Therapeutics shares are held by company insiders. Comparatively, 3.0% of HEXO shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Crescita Therapeutics beats HEXO on 8 of the 12 factors compared between the two stocks.